<--- Back to Details
First PageDocument Content
Biology / Medicine / TRPV1 / Hyperalgesia / Allodynia / Transient receptor potential cation channel /  member A1 / Neuropathic pain / Itch / Ketamine / Pain / Ion channels / Chemistry
Date: 2015-04-07 16:02:11
Biology
Medicine
TRPV1
Hyperalgesia
Allodynia
Transient receptor potential cation channel
member A1
Neuropathic pain
Itch
Ketamine
Pain
Ion channels
Chemistry

Microsoft Word - Session_05_Pain and Nociception.doc

Add to Reading List

Source URL: www.sbfte.org.br

Download Document from Source Website

File Size: 418,55 KB

Share Document on Facebook

Similar Documents

Ion channels / Membrane biology / TRPV1 / Capsazepine / Capsaicin / TRPV / Transient receptor potential channel / Chemistry / Organic chemistry / Discovery and development of TRPV1 antagonists

B’SYS GmbH CHO TRPV1 Cell Line Specification Sheet © B’SYS GmbH

DocID: 1q9uB - View Document

Developmental neuroscience / Growth factors / Neurotrophic factors / Peptide hormones / Proteins / Nerve growth factor / Neuron / Nociceptor / Sensory neuron / TRPV1 / Neurotrophin-3 / Nervous system

Human sensory neurons derived from iPS as a human in vitro model of peripheral pain UMR - GMGF E. Gras Lavigne1; D. Buttigieg1; L. L’Homme1; C. Badja2; M. Ouamer1; R. Steinschneider 1; F. Magdinier2 1 Neuron Experts,

DocID: 1pcm0 - View Document

Biology / Medicine / TRPV1 / Hyperalgesia / Allodynia / Transient receptor potential cation channel /  member A1 / Neuropathic pain / Itch / Ketamine / Pain / Ion channels / Chemistry

Microsoft Word - Session_05_Pain and Nociception.doc

DocID: 1gdST - View Document

Peptide hormones / Cytokines / TRPV1 / Leptin / Capsaicin / 5-HT2A receptor / Ryanodine receptor / TRPV / T helper cell / Biology / Ion channels / T cells

Microsoft Word - Session_01-Cellular and Molecular Pharmacology.doc

DocID: 1fDjk - View Document

Biology / Perception / TRPV1 / Capsaicin / TRPV / Neuropathic pain / Discovery and development of TRPV1 antagonists / Hyperalgesia / Piquance / Pain / Ion channels / Mind

PHE377: A novel clinical-stage TRPV1 antagonist devoid of “class” side effects for the treatment of chronic pain syndromes Summary of the Opportunity PharmEste wishes to identify a partner for development and commerc

DocID: 1aagi - View Document